Carl Zeiss Meditec AG (ETR:AFX) has been given a €48.00 ($56.47) target price by analysts at Berenberg Bank in a report issued on Monday. The firm currently has a “buy” rating on the stock.

Other analysts have also issued research reports about the company. Kepler Capital Markets set a €48.50 ($57.06) target price on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a report on Saturday, May 20th. Commerzbank Ag set a €42.00 ($49.41) target price on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Saturday, May 20th. Independent Research GmbH set a €44.00 ($51.76) target price on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Saturday, May 20th. Deutsche Bank AG set a €40.00 ($47.06) target price on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Friday, July 28th. Finally, Nord/LB set a €52.00 ($61.18) target price on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a report on Friday, June 2nd. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of €45.75 ($53.82).

Carl Zeiss Meditec AG (ETR AFX) traded up 0.225% on Monday, reaching €44.963. The company’s stock had a trading volume of 700 shares. Carl Zeiss Meditec AG has a 12-month low of €30.80 and a 12-month high of €47.80. The stock has a market cap of €4.02 billion and a PE ratio of 32.700. The company’s 50 day moving average price is €45.59 and its 200-day moving average price is €42.02.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/07/carl-zeiss-meditec-ag-etrafx-given-a-48-00-price-target-by-berenberg-bank-analysts.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.